DuoGenic StemCells Corp (ROCO:7607) Stock Price, Trades & News

DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

Financial Strength

5/10

Name	Current	Vs Industry
Cash-To-Debt	2.24
Equity-to-Asset	0.65
Debt-to-Equity	0.44
Debt-to-EBITDA	-1.13
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	7.12	Distress Grey Safe
Beneish M-Score	-2.34	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	39.6
	3-Year EBITDA Growth Rate	14.5
	3-Year EPS without NRI Growth Rate	11.4
	3-Year FCF Growth Rate	28.1
	3-Year Book Growth Rate	-15.9

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	42.53
	9-Day RSI	47.39
	14-Day RSI	47.98
	3-1 Month Momentum %	-19.46
	6-1 Month Momentum %	-30.31
	12-1 Month Momentum %	37.24

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.24
	Quick Ratio	2.15
	Cash Ratio	1.88
	Days Inventory	265.59
	Days Sales Outstanding	53.31
	Days Payable	26.5

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-5.2
	Shareholder Yield %	-13.08

Profitability Rank

1/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	76.33
	Operating Margin %	-124.65
	Net Margin %	-127.48
	EBITDA Margin %	-94.84
	FCF Margin %	-89.28
	OCF Margin %	-89.28
	ROE %	-91.78
	ROA %	-40.41
	ROIC %	-53.91
	3-Year ROIIC %	116.57
	ROC (Joel Greenblatt) %	-130.69
	ROCE %	-82.52

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History
	PS Ratio	21.96
	PB Ratio	9.59
	Price-to-Tangible-Book	9.68
	EV-to-EBIT	-18.66
	EV-to-EBITDA	-24.28
	EV-to-Revenue	23.02
	EV-to-FCF	-26.09
	Price-to-GF-Value	0.27
	Price-to-Net-Current-Asset-Value	15.28
	Price-to-Net-Cash	22.18
	Earnings Yield (Greenblatt) %	-5.36
	FCF Yield %	-3.67

GF Value™: NT$50.58

ROCO:7607

Warning Signs

Warning! GuruFocus detected 2 Severe warning signs with 7607. Try a 7-Day Free Trial to check it out.

DuoGenic StemCells Corp Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

DuoGenic StemCells Corp Stock Events

Financials Calendars

	Event	Date	Price (NT$)
No Event Data

Press Release

	Subject	Date
No Press Release

Articles on DuoGenic StemCells Corp

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.